DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 020717
» See Plans and Pricing
The generic ingredient in PROVIGIL is modafinil. There are twenty-six drug master file entries for this compound. Additional details are available on the modafinil profile page.
Summary for 020717
Tradename: | PROVIGIL |
Applicant: | Cephalon |
Ingredient: | modafinil |
Patents: | 1 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Dec 24, 1998 | TE: | AB | RLD: | Yes | ||||
Patent: | Start Trial | Patent Expiration: | May 29, 2024 | Product Flag? | Substance Flag? | Delist Request? | Y |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Dec 24, 1998 | TE: | AB | RLD: | Yes | ||||
Patent: | Start Trial | Patent Expiration: | May 29, 2024 | Product Flag? | Substance Flag? | Delist Request? | Y |
Expired US Patents for NDA 020717
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-001 | Dec 24, 1998 | Start Trial | Start Trial |
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-002 | Dec 24, 1998 | Start Trial | Start Trial |
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-001 | Dec 24, 1998 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription